Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Cell Reports
|
January 4, 2025
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
Luciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
Blood Advances
|
January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
Serkan Akin, Chitra Hosing, Issa Khouri, et al.
Virchows Archiv : an International Journal of Pathology
|
February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents
Mario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
The New England Journal of Medicine
|
February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marin, Pinaki Banerjee, et al.
Blood
|
December 16, 2021
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia
Mahmoud R Gaballa, Pinaki Banerjee, Denái R Milton, et al.
Haematologica
|
June 4, 2026
Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia
Jennifer Miatech, Denái R Milton, Mahmoud R Gaballa, et al.
Frontiers in Immunology
|
March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Blood Advances
|
December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Li Li, Han Chen, David Marin, et al.
Science Advances
|
July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells
Amanda Olson, Ye Li, David Marin, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Cell Reports
|
January 4, 2025
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
Luciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
Blood Advances
|
January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
Serkan Akin, Chitra Hosing, Issa Khouri, et al.
Virchows Archiv : an International Journal of Pathology
|
February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents
Mario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
The New England Journal of Medicine
|
February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marin, Pinaki Banerjee, et al.
Blood
|
December 16, 2021
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia
Mahmoud R Gaballa, Pinaki Banerjee, Denái R Milton, et al.
Haematologica
|
June 4, 2026
Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia
Jennifer Miatech, Denái R Milton, Mahmoud R Gaballa, et al.
Frontiers in Immunology
|
March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Blood Advances
|
December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Li Li, Han Chen, David Marin, et al.
Science Advances
|
July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells
Amanda Olson, Ye Li, David Marin, et al.
Page
of 9